UK budget

UK Budget
#Association of the British Pharmaceutical Industry #Investment #Life sciences #UK #UK budget

UK Budget promises £70m for life sciences and lifts VAT on free medicines

In the 2026 Budget, Chancellor John Healey moved to settle a long-running VAT issue that had become a barrier to pharmaceutical companies providing free-of-charge medicines to NHS patients. Medicines supplied free of charge can provide a vital route to treatment for patients with serious conditions. Companies supply them through early… Read More

#Business & Investment #News #Trending News

Great British Pounds, Investment
#ABPI #Life sciences #UK budget #UK economy #UK government

UK Chancellor backs life sciences in the Budget

The UK’s Labour Government has announced its first budget, which focuses on stability, investment, and long-term growth. Key announcements in the Budget included increases in NHS funding, a £520m life sciences innovative manufacturing fund, and investment in research and development, including increased funding for the National… Read More

#News #Trending News

#Association of the British Pharmaceutical Industry #Life sciences #UK budget #UK economy #UK government

Calls for life sciences and new medicines support in UK Budget

With a new UK Budget looming on 30 October, the first of this new Labour government, the Chancellor has been urged to protect the country’s life sciences sector and increase investment in medicines. Concerns have been raised in response to rumours of potential cuts to UK… Read More

#News

#Brexit #European Commission #European Medicines Agency #MHRA #Regulatory #UK #UK budget

Two part commentary on Brexit and drug discovery

On 31 January 2020, the United Kingdom (UK) withdrew from the European Union (EU). Alongside a number of repercussions, the most impactful to the drug discovery sector arguably relates to regulatory affairs on account of adjusting from the European Medicines Agency (EMA) to the Medicines and Healthcare products Regulatory… Read More

#News

#Brexit #European Commission #European Medicines Agency #MHRA #Regulatory #UK #UK budget

Part 1: What impact has Brexit had on UK drug discovery?

On 31 January 2020, the United Kingdom (UK) withdrew from the European Union (EU). Alongside a number of repercussions, the most impactful to the drug discovery sector arguably relates to regulatory affairs on account of adjusting from the European Medicines Agency (EMA) to the Medicines and Healthcare products Regulatory Agency… Read More

#Exclusive Content #Regulatory

Chancellor Jeremy Hunt and the Spring Budget
#Association of the British Pharmaceutical Industry #BioIndustry Association #Investment #Life sciences #MHRA #Regulatory #UK #UK budget #UK government

UK Spring Budget a ‘vote of confidence’ in UK life sciences

There was some good news for the UK life sciences sector in the government’s Spring Budget, but did it go far enough? DDW’s Diana Spencer takes a look at the industry’s reaction. There wasn’t much to write home about in the UK government’s Spring Budget, described by Bloomberg UK’s Marcus… Read More

#Business & Investment #Exclusive Content

Downing Street, London, UK
#BioIndustry Association #Biotechnology #Research & development #UK budget #UK government

Industry calls on UK Government to support biotech SMEs

Ahead of the UK’s Spring Budget, the UK BioIndustry Association (BIA) is calling on the Treasury to provide additional support through the R&D tax relief scheme to R&D intensive SMEs. These companies are the most at risk from the R&D tax relief rate cut announced at… Read More

#News

Rishi Sunak presenting the UK budget
#Academy of Medical Sciences #BioIndustry Association #Biomedical research #Cancer Research UK #Economy #Funding #Investment #UK budget #UK economy #UK government

UK biomedical organisations warn against research cuts 

Ahead of the UK Government’s Autumn Statement on Thursday, leading biomedical research companies, charities and institutions have called for the Chancellor to place medical and health research at the heart of plans for growth.  The letter has been signed by the Academy of Medical Sciences, Pfizer, Wellcome,… Read More

#News